SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Therapeutic Advances in Cardiovascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1753944708096282v1
3/1/29    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sala, M.
Right arrow Articles by Brambilla, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sala, M.
Right arrow Articles by Brambilla, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Electrophysiological changes of cardiac function during antidepressant treatment

Michela Sala

Azienda Sanitaria Locale di Alessandria, Presidio di Casale Monferrato, Department of Mental Health, (Italy) University of Pavia, Pavia (Italy)-Interdepartmental Center for Research on Personality Disorders, Department of Applied and Behavioural Health Sciences, Section of Psychiatry, michelasalacap{at}yahoo.it

Matteo Lazzaretti

University of Pavia, Pavia (Italy)-Interdepartmental Center for Research on Personality Disorders, Department of Applied and Behavioural Health Sciences, Section of Psychiatry

Giulia De Vidovich

University of Pavia, Pavia (Italy)-Interdepartmental Center for Research on Personality Disorders, Department of Applied and Behavioural Health Sciences, Section of Psychiatry

Edgardo Caverzasi

University of Pavia, Pavia (Italy)-Interdepartmental Center for Research on Personality Disorders, Department of Applied and Behavioural Health Sciences, Section of Psychiatry

Francesco Barale

University of Pavia, Pavia (Italy)-Interdepartmental Center for Research on Personality Disorders, Department of Applied and Behavioural Health Sciences, Section of Psychiatry

Giorgio d'Allio

Azienda Sanitaria Locale di Alessandria, Presidio di Casale Monferrato, Department of Mental Health, (Italy)

Paolo Brambilla

University of Udine, Udine (Italy), Inter University Centre for Behavioural Neurosciences, Department of Physiology and Experimental and Clinical Medicine Scientific Institute for Research and Health Care E.Medea, Udine (Italy)

Some antidepressant agents can cause electrophysiological changes of cardiac function leading to ventricular arrhythmias and sudden death. However, antidepressants have also protective effects on the heart through their capacity to modulate cardiac autonomic-mediated physiological responses. Heart rate variability and QTc length are two strictly linked parameters that allow us to appreciate the effects of different drugs on cardiac physiology. Heart rate variability reflects functioning of the autonomic nervous system and possibly also regulation by the limbic system. Autonomic regulation of cardiac activity influences also cardiac repolarization and QT length, both directly and via its effects on heart rate. In this review we present the methodologies adopted to study the effect of antidepressant drugs on QT length and heart rate variability and we summarize data on electrophysiological changes related to antidepressant treatment. Clinical implications for the choice of different antidepressants in different clinical populations are discussed.

Key Words: heart rate • long-QT syndrome • tachyarrhythmias

This version was published on February 1, 2009

Therapeutic Advances in Cardiovascular Disease, Vol. 3, No. 1, 29-43 (2009)
DOI: 10.1177/1753944708096282


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement